• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Dexcom unveils new advocates to support World Diabetes Day campaign

November 14, 2025 By Sean Whooley

Dexcom World Diabetes Day map graphic
A map view of the new diabetes advocates. [Image courtesy of Dexcom]
Dexcom (NSDQ:DXCM) today announced 16 new advocates representing people with diabetes as part of its World Diabetes Day campaign.

Today, Nov. 14, is World Diabetes Day, which marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National Diabetes Awareness Month.

(We compiled lists in 2021, 2022, 2023 and 2024, highlighting some of the industry-wide initiatives for these occasions. Here’s what Dexcom did last year.)

Dexcom’s latest initiative selected 16 advocates from all over the world out of 1,000 open-call submissions. The advocates, ranging from ages six to 68, have different types of diabetes and represent four continents and five countries. Each person’s selection was based on their experience advocating for people with diabetes in their communities. The company said each advocate shares a common passion for advocacy and for the company’s glucose biosensing technology.

According to Dexcom, its effort marks the first time it looked to source voices from the broader diabetes community specifically for its World Diabetes Day campaign. It highlights personal stories about diabetes, misconceptions the advocates would like to dispel and how they would like to inspire others.

Dexcom welcomed the advocates to a photoshoot in Los Angeles that included Grammy-nominated artist, actor, producer and Dexcom user Lance Bass, as well as author, producer, actress and Stelo over-the-counter CGM ambassador Retta. Tommy Lundberg, who lives with type 1 diabetes, served as the photographer for the photoshoot.

“Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique and compelling story, but they are all bonded by the shared experience of living with diabetes and passion for helping others in their diabetes journey,” said Lundberg. “I’m looking forward to people around the world seeing the strength of their advocacy shine through in this meaningful campaign.”

The new Dexcom Diabetes Advocates

  • Ben Schwinof: Portland, OR, United States | Age 50, Type 2 Diabetes 
  • Bridget Curran: New York, NY, United States | Age 56, Prediabetes 
  • Bruce Moss: Durango, CO, United States | Age 67, Type 1 Diabetes 
  • Cindy Reinl: Stuttgart, Germany | Age 26, Type 1 Diabetes 
  • Darrell Byers: Boston, United States | Age 64, Type 2 Diabetes 
  • Isabelle da Silva: Boca Raton, FL, United States | Age 6, Type 1 Diabetes 
  • Jacob Cain: Mesa, AZ, United States | Age 49, Type 2 Diabetes 
  • Kari Cichoski: Las Vegas, NV, United States | Age 38, Type 1 Diabetes
  • Kate Beaulieu: Toronto, ON, Canada | Age 20, Type 1 Diabetes 
  • Kaye Peterson: Lebanon, KY, United States | Age 68, Type 1 Diabetes 
  • Lachie Kennedy: Brisbane, Australia | Age 22, Type 1 Diabetes 
  • Maria Alejandra Jove Valerio: Boston, MA, United States | Age 20, Type 1 Diabetes
  • MiYeong Kim: Seoul, South Korea | Age 48, Mother to a Son with Type 1 Diabetes
  • Sofia Pansini: Boston, MA, United States | Age 21, Type 1 Diabetes 
  • Tajah Russell: Dallas, TX, United States | Age 31, Type 1 Diabetes
  • Tai’yon Allen Walker: Annapolis, MD, United States | Age 11, Type 1 Diabetes

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

IN CASE YOU MISSED IT

  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance
  • Medtronic moves to divest final stake in MiniMed
  • Dexcom adds former Stryker CFO to board
  • MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS